FdaApplication

ANDA 205258

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAPOTEX INC
application_typeANDA
approval_date2014-04-03

Products (1)

ProductActive ingredientStrengthDosage form
NEVIRAPINENEVIRAPINE400MGTABLET, EXTENDED RELEASE;ORAL

1 product